Morpholine

Morpholine

SCHEMBL7985369

C1COCCN1.CCOc1cccc(C(=O)O)c1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 2/20 0.56
KMT2A Q03164 2/20 0.56
RXRA P19793 1/20 0.52
RXRB P28702 1/20 0.52
SMN1; SMN2 Q16637 5/20 0.51
TP53 P04637 1/20 0.51
PKM P14618 1/20 0.51
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
MRGPRX4 Q96LA9 1/20 0.51
RAB9A P51151 3/20 0.49
HPGD P15428 3/20 0.49
NR4A2 P43354 2/20 0.49
NPC1 O15118 2/20 0.47
MITF O75030 1/20 0.47
PAX8 Q06710 1/20 0.47
LMNA P02545 1/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Morpholine SCHEMBL7988982 0.88 RAB9A (0.46) NR1H4KMT2ARXRARXRBSMN1; SMN2
SCHEMBL29505938 0.84 KMT2A (0.75) NR1H4KMT2ARXRARXRBSMN1; SMN2
SCHEMBL1333545 0.84 KMT2A (0.75) NR1H4KMT2ARXRARXRBSMN1; SMN2
SCHEMBL29505934 0.84 KMT2A (0.75) NR1H4KMT2ARXRARXRBSMN1; SMN2
Morpholine SCHEMBL7989270 0.83 PLA2G4B (0.59) RXRARXRBSMN1; SMN2TP53HPGD
Hydrochloric Acid SCHEMBL30608606 0.83 KMT2A (0.73) NR1H4KMT2ARXRARXRBSMN1; SMN2
Morpholine SCHEMBL7984701 0.81 SMN1; SMN2 (0.48) KMT2ASMN1; SMN2TP53PKMNFKB1
Isophthalic Acid SCHEMBL15570863 0.78 KMO (0.51) KMT2ASMN1; SMN2RAB9AHPGDLMNA
Isophthalic Acid SCHEMBL15572812 0.78 KMO (0.51) KMT2ASMN1; SMN2RAB9AHPGDLMNA
Benzoic Acid SCHEMBL11879027 0.78 TSHR (0.48) KMT2ASMN1; SMN2RAB9ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed